Ozer, Hatice G
Mayo Clinic
From Ohio State University Comprehensive Cancer Center, Columbus (J.A.W., A.S.R., N.A.H., W.Z., K.A.R., G.L., J.S.B., H.G.O., J.C.B.); the Alliance Statistics and Data Center (A.S.R., A.M.B., B.M.-E., B.F., S.J.M.), Mayo Clinic (W.D., S.A.P., M.L.), Roches
Citations 1
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Woyach, Jennifer A. , Ruppert, Amy S. , Heerema, Nyla A. , Zhao, Weiqiang , Booth, Allison M., Ding, Wei , Bartlett, Nancy L. , Brander, Danielle M. , Rogers, Kerry A. , Hurria, Arti , Brown, Jennifer R. , Lozanski, Gerard , Özer, Hatice Gülçin , Major‐Elechi, Brittny , Fruth, Briant, Nattam, Sreenivasa, Litzow, Mark R. , Owen, Carolyn , Kuzma, Charles, Little, Richard F. , Smith, Scott E. , Stone, Richard M. , Mandrekar, Sumithra J. , Byrd, John C., Byrd, John C. , Barr, Paul M. , Coutré, Steven , Blachly, James S. , Ozer, Hatice G, Major-Elechi, Brittny, Ding, Wei , Bartlett, Nancy L , Parikh, Sameer A. , Larson, Richard A. , Erba, Harry Paul , Abramson, Jeremy S. , Byrd, John C. , Byrd, John C
New England Journal of Medicine | December 1, 2018 | Volume: 379 | Issue: 26 | Pages: 2517-2528
